
ASCENTAGE PHARMA GR-ADR
AAPG · NASDAQ
Updated at 2026-10-14 12:34:30
- Today's High
- $16.07
- Today’s Low
- $14.83
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $15.19
- Previous Close
- $15.31
- Volume
- 4.69K
- Market Cap
- $10.49B
- P/E Ratio
- --
- EPS
- $-3.94
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- SUZHOU INDUSTRIAL PARK, SUZHOU, CHINA, 215000
- Country
- CN
- Listing Date
- 2019-10-28
- Fiscal Year End
- December
- Shares Outstanding
- 373.56M
- CIK
- --
- Website
- www.ascentage.cn
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.
Financial Metrics
Revenue
2026-06-30
$298.87M
2026-03-31
$334.13M
2025-12-31
$334.13M
2025-06-30
$233.69M
Operating Expenses
2026-06-30
$994.81M
2026-03-31
$906.3M
2025-12-31
$906.3M
2025-06-30
$766.03M
Net Income
2026-06-30
-$807.68M
2026-03-31
-$639.95M
2025-12-31
-$639.95M
2025-06-30
-$590.76M
Net Profit Margin
2026-06-30
-270.23%
2026-03-31
-191.52%
2025-12-31
-191.52%
2025-06-30
-252.79%
Earnings Per Share
2026-06-30
--
2026-03-31
$0.00
2025-12-31
--
2025-06-30
$-1.73
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$701.07M
2026-03-31
-$598.95M
2025-12-31
-$598.95M
2025-06-30
-$510.03M
Effective Tax Rate
2026-06-30
-1.69%
2026-03-31
-0.21%
2025-12-31
-0.21%
2025-06-30
-0.94%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $298.87M | $334.13M | $334.13M | $233.69M |
| Operating Expenses | $994.81M | $906.3M | $906.3M | $766.03M |
| Net Income | -$807.68M | -$639.95M | -$639.95M | -$590.76M |
| Net Profit Margin | -270.23% | -191.52% | -191.52% | -252.79% |
| Earnings Per Share | -- | $0.00 | -- | $-1.73 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$701.07M | -$598.95M | -$598.95M | -$510.03M |
| Effective Tax Rate | -1.69% | -0.21% | -0.21% | -0.94% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.